Alternatively, a lenti-CRSIPR/Cas9-YME1L-knockout (KO)-puro construct was transduced to Cas9-expressing P1 glioma cells, and single stable cells (“koYME1L”) were established following selection and YMEL1 KO screening. This evidence concerns the gene YME1L1 and central nervous system cancer.